Table 2 Treatment details for women with advanced stage ovarian cancer stratified by age, N (%)
Age group (Age at diagnosis, years) | p-Value | |||
|---|---|---|---|---|
Characteristics | Total (n = 3584) | 65–74 (n = 2296) | ≥ 75 (n = 1288) | |
Stage | 0.921 | |||
IIIC IV | 2127(59.3) 1457(40.7) | 1364(59.4) 932(40.6) | 763(59.2) 525(40.8) | |
LND | < 0.001 | |||
Non-LN 1–9 LNs 10–19 LNs ≥ 20 LNs Unknown | 1963(54.8) 841(23.5) 378(10.5) 318(8.9) 163(2.3) | 1197(52.1) 555(24.2) 255(11.1) 236(10.3) 53(2.3) | 766(59.5) 286(22.2) 123(9.5) 82(6.4) 31(2.4) | |
Surgery method | < 0.001 | |||
No surgery USO/BSO ± Hys USO/ BSO&Ome ± Hys | 363(10.1) 290(8.1) 587(16.4) | 157(6.8) 172(7.5) 377(16.4) | 206(16.0) 118(9.2) 210(16.3) | |
Debulking Pelvic exenteration | 2250(62.8) 94(2.6) | 1519(66.2) 71(3.1) | 731(56.8) 23(1.8) | |
Treatment type | < 0.001 | |||
Chemo + surgery Surgery Chemo No chemo or surgery | 2860(79.8) 361(10.1) 261(7.3) 126(2.8) | 1951(85.0) 188(8.2) 124(5.4) 33(1.4) | 909(70.6) 173(13.4) 137(10.6) 69(5.4) | |
NACT | 0.212 | |||
No Yes | 1801(63.0) 1059(37.0) | 1244(63.8) 707(36.2) | 557(61.3) 352(38.7) | |
Residual disease | < 0.001 | |||
PDS/Optimal IDS/ Optimal PDS/Suboptimal IDS/Suboptimal No surgery Unknown | 1184(33.0) 592(16.5) 421(11.7) 237(6.7) 363(10.1) 787(22.0) | 803(35.0) 407(17.7) 275(12.0) 151(6.6) 157(6.8) 503(21.9) | 381(29.6) 185(14.4) 146(11.3) 86(6.7) 206(16.0) 284(22.0) | |